External validation of the ETV success score in 313 pediatric patients: a Brazilian single-center study

Leopoldo Mandic Ferreira Furtado1, José Aloysio da Costa Val Filho2, Eustaquio Claret Dos Santos Júnior2

  • 1Department of Pediatric Neurosurgery, Vila da Serra Hospital, Alameda Oscar Niemeyer, 499, Nova Lima, Minas Gerais, 34000-000, Brazil. lmandicster@gmail.com.

Neurosurgical Review
|January 3, 2021
PubMed

Insights

The endoscopic third ventriculostomy (ETV) success score (ETVSS) may underestimate ETV success rates at 6 and 12 months in children. However, ETVSS remains a useful tool for predicting ETV outcomes in clinical decision-making.

Area of Science:

  • Neurosurgery
  • Pediatric Neurosurgery
  • Hydrocephalus Management

Background:

  • The endoscopic third ventriculostomy (ETV) success score (ETVSS) predicts ETV success at 6 months.
  • External validation of ETVSS performance beyond 6 months is needed.

Purpose of the Study:

  • To assess the performance of the ETVSS at 12 months post-procedure.
  • To externally validate the ETVSS in a Brazilian pediatric cohort.

Main Methods:

  • Retrospective analysis of 313 children undergoing their first ETV.
  • ETVSS calculated and compared with actual success at 6 and 12 months.
  • Analysis of etiologies including aqueductal stenosis and brain tumors.

Main Results:

  • ETV success at 6 months was 73.16%, higher than the 61.3% predicted by ETVSS.
  • Actual success rate at 12 months was 65.1%.
  • Area under the ROC curve suggested ETVSS tended to underestimate success at both 6 and 12 months.

Conclusions:

  • The ETVSS demonstrates good predictive capability for ETV success, despite a tendency to underestimate actual outcomes.
  • ETVSS is a valuable tool for guiding clinical decisions regarding ETV in pediatric patients.
  • The score's utility extends to 12-month follow-up, supporting its use in long-term management.